A novel application for murine double minute 2 antagonists - The p53 tumor suppressor network also controls angiogenesis

被引：14

作者：

Binder, Bernd R. ^{[1
]}

机构：

[1] Med Univ Vienna, Ctr Biomol Med & Pharmacol, Dept Vasc Biol & Thrombosis Res, A-1090 Vienna, Austria

来源：

CIRCULATION RESEARCH | 2007年 / 100卷 / 01期

关键词：

angiogenesis; MDM2; p53; nutlin-3;

D O I：

10.1161/01.RES.0000255897.84337.38

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：13 / 14

页数：2

共 24 条

[1] MDM2 is a central node in the p53 pathway: 12 years and counting [J].

Bond, GL ;

Hu, WW ;

Levine, AJ .

CURRENT CANCER DRUG TARGETS, 2005, 5 (01) :3-8

[2] A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans [J].

Bond, GL ;

Hu, WW ;

Bond, EE ;

Robins, H ;

Lutzker, SG ;

Arva, NC ;

Bargonetti, J ;

Bartel, F ;

Taubert, H ;

Wuerl, P ;

Onel, K ;

Yip, L ;

Hwang, SJ ;

Strong, LC ;

Lozano, G ;

Levine, AJ .

CELL, 2004, 119 (05) :591-602

[3] Angiogenesis in health and disease [J].

Carmeliet, P .

NATURE MEDICINE, 2003, 9 (06) :653-660

[4] Small-molecule inhibitors of the p53 suppressor HDM2: have protein-protein interactions come of age as drug targets? [J].

Fischer, PM ;

Lane, DP .

TRENDS IN PHARMACOLOGICAL SCIENCES, 2004, 25 (07) :343-346

[5] Angiogenesis-dependent diseases [J].

Folkman, J .

SEMINARS IN ONCOLOGY, 2001, 28 (06) :536-542

[6] Small molecule inhibitors of p53/MDM2 interaction [J].

Fotouhi, N ;

Graves, B .

CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2005, 5 (02) :159-165

[7] Identification of an aberrantly spliced form of HDMX in human tumors: A new mechanism for HDM2 stabilization [J].

Giglio, S ;

Mancini, F ;

Gentiletti, F ;

Sparaco, G ;

Felicioni, L ;

Barassi, F ;

Martella, C ;

Prodosmo, A ;

Iacovelli, S ;

Buttitta, F ;

Farsetti, A ;

Soddu, S ;

Marchetti, A ;

Sacchi, A ;

Pontecorvi, A ;

Moretti, F .

CANCER RESEARCH, 2005, 65 (21) :9687-9694

[8]

Hainaut P, 2000, ADV CANCER RES, V77, P81

[9] Protein-protein interactions for cancer therapy [J].

Harris, CC .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (06) :1659-1660

[10] P53 MUTATIONS IN HUMAN CANCERS [J].

HOLLSTEIN, M ;

SIDRANSKY, D ;

VOGELSTEIN, B ;

HARRIS, CC .

SCIENCE, 1991, 253 (5015) :49-53

← 1 2 3 →